1.
SARS-CoV-2 specific T-cells are generated in less than half of allogeneic HSCT recipients failing to seroconvert after COVID-19 vaccination
Jarisch, A., Wiercinska, E., Daqiq-Mirdad, S., Hellstern, H., Ajib, S., Cremer, A., Nguyen, N. T. T., Dukat, A., Ullrich, E., Ciesek, S., et al
European journal of immunology. 2022